Pfizer [NYSE: PFE] Announces Agreement with UK Government
Pfizer Inc. [NYSE: PFE] disclosed that it has inked an additional agreement with the UK government to supply an additional 2.5 million treatment options of its investigational candidate PAXLOVID. This is in addition to the 250,000 treatment courses earlier committed to the UK Government. The full amount of treatment courses reached 2.75 million. Pfizer is […]